Pediatrics · Rayne, LA
NPI
1043210271
Since 2005
Specialty
Pediatrics
Code 208000000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
717 Curtis Dr
Rayne, LA, 70578
Phone (337) 334-7551
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,270
41 services
Medicare patients, 2024
21
Average age 76
Drug cost, 2024
$1.2M
17,655 prescriptions
Company payments, 2025
$320
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark Dawson was code G0179 (physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a), 18 times for 11 patients. In total Mark Dawson billed 41 services in 10 codes, and Medicare paid $1,270.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-05-10.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 18 | 11 | $30.41 | $547 |
By year: 2022 $5,692 for 118 services; 2023 $2,218 for 60 services; 2024 $1,270 for 41 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark Dawson prescribed most often to Medicare patients was Atorvastatin Calcium, with 681 prescriptions and refills. In total Mark Dawson wrote 17,655 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 681 | 1,056 | 110 | $8,059 |
| Amlodipine Besylate Generic | 611 | 1,033 | 109 | $4,349 |
| Levothyroxine Sodium Generic | 585 | 786 | 74 | $7,551 |
| Lisinopril Generic | 457 | 872 | 97 | $3,288 |
| Pantoprazole Sodium Generic | 447 | 671 | 86 | $7,543 |
| Furosemide Generic | 433 | 600 | 76 | $2,478 |
| Metformin Hcl Generic | 401 | 569 | 62 | $4,257 |
| Tamsulosin Hcl Generic | 389 | 586 | 67 | $8,511 |
| Metoprolol Succinate Generic | 314 | 583 | 67 | $4,345 |
| Simvastatin Generic | 306 | 511 | 52 | $2,701 |
| Omeprazole Generic | 291 | 391 | 47 | $3,251 |
| Gabapentin Generic | 281 | 355 | 51 | $4,189 |
| Risperidone Generic | 254 | 258 | 25 | $5,326 |
| Trazodone Hcl Generic | 233 | 346 | 38 | $3,969 |
| Alprazolam Generic | 224 | 238 | 33 | $1,052 |
Brand drugs: 1,968 claims; generic drugs: 15,503 claims; opioid claims: 163.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark Dawson $320 ($320 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $84.22.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 4 | $84.22 |
| Exact Sciences Corporation EXAS | 2 | $40.35 |
| Sanofi-Aventis U.S. LLC SNY | 2 | $32.76 |
| Kowa Pharmaceuticals America, Inc. | 1 | $26.14 |
| Collegium Pharmaceutical, Inc. COLL | 1 | $21.21 |
| Novo Nordisk Inc NVO | 1 | $20.27 |
| Corium, LLC | 1 | $18.97 |
| Esperion Therapeutics, Inc. ESPR | 1 | $18.08 |
| Lilly USA, LLC LLY | 1 | $16.4 |
| Bioventus LLC BVS | 1 | $16.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.